UseGrants

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

National Institutes of HealthAmount not specifiedNo deadline listedForecasted
View on Grants.gov →

This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.

This is a forecasted NIH opportunity (U01 cooperative agreement) for genomic and biologic therapies targeting Alzheimer's disease and related dementias (ADRD), with clinical trials optional. The fu…

Deadline
Not specified
Posted
Feb 12, 2026
Award amount
Amount not specified

In plain English

This is a forecasted NIH opportunity (U01 cooperative agreement) for genomic and biologic therapies targeting Alzheimer's disease and related dementias (ADRD), with clinical trials optional. The full announcement is not yet published, so eligibility, funding amounts, and deadlines are unavailable; U01 awards generally go to universities and research institutions. Watch for the formal NOFO before preparing an application.

AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.

Let AI draft your application

Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.

Application Kit — $49 one-time

Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.

Get the Application Kit

Related grants

Other open grants from National Institutes of Health — soonest deadline first.

Also listed under National Institutes of Health.

Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.